Claudio Prieto

650 total citations
41 papers, 519 citations indexed

About

Claudio Prieto is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Claudio Prieto has authored 41 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Genetics and 12 papers in Infectious Diseases. Recurrent topics in Claudio Prieto's work include Virus-based gene therapy research (13 papers), Rabies epidemiology and control (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Claudio Prieto is often cited by papers focused on Virus-based gene therapy research (13 papers), Rabies epidemiology and control (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Claudio Prieto collaborates with scholars based in Argentina, United States and Uruguay. Claudio Prieto's co-authors include Ricardo Kratje, Marina Etcheverrigaray, Diego O. Serra, Osvaldo Yantorno, Alejandra Bosch, Jürgen Schmitt, D. Naumann, José Luís Bocco, Nicolás P. Koritschoner and Fernando J. López-Díaz and has published in prestigious journals such as Analytical Biochemistry, Oncogene and Applied Microbiology and Biotechnology.

In The Last Decade

Claudio Prieto

41 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Prieto Argentina 11 266 124 76 74 71 41 519
Elena Lantero Spain 12 126 0.5× 88 0.7× 31 0.4× 87 1.2× 109 1.5× 19 497
Kenneth Alibek Kazakhstan 14 210 0.8× 57 0.5× 65 0.9× 25 0.3× 173 2.4× 22 552
Eun‐Sil Park Japan 16 252 0.9× 133 1.1× 168 2.2× 31 0.4× 126 1.8× 63 794
Soraia Attie Calil Jorge Brazil 15 361 1.4× 142 1.1× 73 1.0× 79 1.1× 65 0.9× 56 597
Kelvin Eckert Germany 12 538 2.0× 131 1.1× 131 1.7× 115 1.6× 47 0.7× 15 829
Min‐Hsuan Lin Australia 16 292 1.1× 85 0.7× 175 2.3× 166 2.2× 91 1.3× 30 637
Man Teng China 19 564 2.1× 168 1.4× 122 1.6× 33 0.4× 417 5.9× 63 1.1k
Deepa Patel United States 13 199 0.7× 78 0.6× 136 1.8× 25 0.3× 48 0.7× 18 502
Na Yang China 17 188 0.7× 30 0.2× 49 0.6× 83 1.1× 248 3.5× 44 843
Sarah Burroughs Tencza United States 13 193 0.7× 50 0.4× 82 1.1× 139 1.9× 70 1.0× 15 426

Countries citing papers authored by Claudio Prieto

Since Specialization
Citations

This map shows the geographic impact of Claudio Prieto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Prieto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Prieto more than expected).

Fields of papers citing papers by Claudio Prieto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Prieto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Prieto. The network helps show where Claudio Prieto may publish in the future.

Co-authorship network of co-authors of Claudio Prieto

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Prieto. A scholar is included among the top collaborators of Claudio Prieto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Prieto. Claudio Prieto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Álvarez, Diego E., et al.. (2023). A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied Microbiology and Biotechnology. 107(11). 3429–3441. 3 indexed citations
2.
Álvarez, Diego E., et al.. (2023). Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes. Applied Microbiology and Biotechnology. 107(11). 3495–3508. 4 indexed citations
3.
Prieto, Claudio, et al.. (2023). Optimization and Validation of a Liquid Formulation for a New Recombinant Veterinary Product using QbD Approach. Journal of Pharmaceutical Sciences. 112(11). 2756–2765. 2 indexed citations
4.
Prieto, Claudio, et al.. (2022). Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein. Applied Microbiology and Biotechnology. 106(23). 7933–7948. 3 indexed citations
5.
Kratje, Ricardo, et al.. (2022). Screening of CHO-K1 endogenous promoters for expressing recombinant proteins in mammalian cell cultures. Plasmid. 119-120. 102620–102620. 7 indexed citations
6.
Kratje, Ricardo, et al.. (2021). Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications. Applied Microbiology and Biotechnology. 106(2). 579–592. 2 indexed citations
7.
Prieto, Claudio, et al.. (2021). Detection and quantification of anti-rabies glycoprotein antibodies: current state and perspectives. Applied Microbiology and Biotechnology. 105(18). 6547–6557. 8 indexed citations
8.
9.
Etcheverrigaray, Marina, et al.. (2021). Development, Production, and Characterization of Hepatitis B Subviral Envelope Particles as a Third-Generation Vaccine. Methods in molecular biology. 2410. 273–287. 1 indexed citations
10.
Etcheverrigaray, Marina, et al.. (2020). Rabies VLPs adjuvanted with saponin-based liposomes induce enhanced immunogenicity mediated by neutralizing antibodies in cattle, dogs and cats. Journal of Virological Methods. 286. 113966–113966. 9 indexed citations
11.
Zan, María M. De, et al.. (2019). Activity-Structure Study on the Peptide Fraction of AG2: a Potent In Vitro Transfection Agent. Applied Biochemistry and Biotechnology. 189(2). 661–679. 2 indexed citations
12.
Arias, Diego G., Fernando E. Herrera, Claudio Prieto, et al.. (2016). Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase. European Journal of Medicinal Chemistry. 125. 1088–1097. 25 indexed citations
13.
Etcheverrigaray, Marina, et al.. (2016). Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies. Methods in molecular biology. 1403. 155–166. 6 indexed citations
14.
Kratje, Ricardo, et al.. (2015). Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate. Vaccine. 33(35). 4238–4246. 42 indexed citations
15.
Kratje, Ricardo, et al.. (2014). Rabies virus-like particles expressed in HEK293 cells. Vaccine. 32(24). 2799–2804. 38 indexed citations
16.
Prieto, Claudio, et al.. (2014). Target cells for antibodies detection in rabies vaccine control. Vaccine. 32(24). 2805–2807. 3 indexed citations
17.
Prieto, Claudio, et al.. (2012). WISH cell line: From the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β. Journal of Immunological Methods. 381(1-2). 70–74. 18 indexed citations
18.
Prieto, Claudio, et al.. (2006). Effect of sodium butyrate and zinc sulphate supplementation on recombinant human IFN-β production by mammalian cell culture. Latin American Applied Research - An international journal. 36(4). 321–327. 4 indexed citations
19.
Gehrau, Ricardo C., Diego S. D’Astolfo, Claudio Prieto, José Luís Bocco, & Nicolás P. Koritschoner. (2005). Genomic organization and functional analysis of the gene encoding the Krüppel-like transcription factor KLF6. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1730(2). 137–146. 14 indexed citations
20.
Slavin, Daniela A, Nicolás P. Koritschoner, Claudio Prieto, et al.. (2004). A new role for the Krüppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Oncogene. 23(50). 8196–8205. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Lantero Breakdown of academic impact, for papers by Kenneth Alibek Breakdown of academic impact, for papers by Eun‐Sil Park Breakdown of academic impact, for papers by Soraia Attie Calil Jorge Breakdown of academic impact, for papers by Kelvin Eckert Breakdown of academic impact, for papers by Min‐Hsuan Lin Breakdown of academic impact, for papers by Man Teng Breakdown of academic impact, for papers by Deepa Patel Breakdown of academic impact, for papers by Na Yang Breakdown of academic impact, for papers by Sarah Burroughs Tencza
Rankless by CCL
2026